Interleukin-36 receptor antagonist is associated with the progression of renal cell carcinoma
- Type
- Retraction
- Notice date
- 3/3/2021 0:00
- Journal
- International Immunopharmacology
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.intimp.2021.107483
- Original paper DOI
- 10.1016/j.intimp.2020.106474